vs

Side-by-side financial comparison of PRECISION BIOSCIENCES INC (DTIL) and Stran & Company, Inc. (SWAG). Click either name above to swap in a different company.

PRECISION BIOSCIENCES INC is the larger business by last-quarter revenue ($34.2M vs $28.9M, roughly 1.2× Stran & Company, Inc.). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs 0.8%, a 58.0% gap on every dollar of revenue. On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs 7.2%). Stran & Company, Inc. produced more free cash flow last quarter ($38.0K vs $-11.3M). Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs 24.0%).

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

Stran & Company, Inc. provides branded promotional products, custom merchandise and integrated marketing solutions for corporate clients. It serves customers across retail, healthcare, technology, education and other sectors, supporting brand campaigns, customer engagement and employee incentive programs.

DTIL vs SWAG — Head-to-Head

Bigger by revenue
DTIL
DTIL
1.2× larger
DTIL
$34.2M
$28.9M
SWAG
Growing faster (revenue YoY)
DTIL
DTIL
+5253.9% gap
DTIL
5261.1%
7.2%
SWAG
Higher net margin
DTIL
DTIL
58.0% more per $
DTIL
58.9%
0.8%
SWAG
More free cash flow
SWAG
SWAG
$11.3M more FCF
SWAG
$38.0K
$-11.3M
DTIL
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
24.0%
SWAG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DTIL
DTIL
SWAG
SWAG
Revenue
$34.2M
$28.9M
Net Profit
$20.1M
$243.0K
Gross Margin
30.4%
Operating Margin
36.6%
-0.1%
Net Margin
58.9%
0.8%
Revenue YoY
5261.1%
7.2%
Net Profit YoY
213.5%
141.5%
EPS (diluted)
$2.62
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DTIL
DTIL
SWAG
SWAG
Q4 25
$34.2M
$28.9M
Q3 25
$13.0K
$26.0M
Q2 25
$18.0K
$32.6M
Q1 25
$29.0K
$28.7M
Q4 24
$638.0K
$27.0M
Q3 24
$576.0K
$20.1M
Q2 24
$49.9M
$16.7M
Q1 24
$17.6M
$18.8M
Net Profit
DTIL
DTIL
SWAG
SWAG
Q4 25
$20.1M
$243.0K
Q3 25
$-21.8M
$-1.2M
Q2 25
$-23.5M
$643.0K
Q1 25
$-20.6M
$-393.0K
Q4 24
$-586.0K
Q3 24
$-16.4M
$-2.0M
Q2 24
$32.7M
$-1.0M
Q1 24
$8.6M
$-491.0K
Gross Margin
DTIL
DTIL
SWAG
SWAG
Q4 25
30.4%
Q3 25
27.2%
Q2 25
30.3%
Q1 25
29.6%
Q4 24
32.5%
Q3 24
29.5%
Q2 24
32.8%
Q1 24
29.8%
Operating Margin
DTIL
DTIL
SWAG
SWAG
Q4 25
36.6%
-0.1%
Q3 25
-158976.9%
-6.9%
Q2 25
-121538.9%
1.2%
Q1 25
-76248.3%
-1.9%
Q4 24
-3.5%
Q3 24
-3693.6%
-10.8%
Q2 24
48.4%
-6.6%
Q1 24
-23.8%
-3.5%
Net Margin
DTIL
DTIL
SWAG
SWAG
Q4 25
58.9%
0.8%
Q3 25
-167476.9%
-4.8%
Q2 25
-130666.7%
2.0%
Q1 25
-70913.8%
-1.4%
Q4 24
-2.2%
Q3 24
-2851.6%
-10.1%
Q2 24
65.6%
-6.1%
Q1 24
48.8%
-2.6%
EPS (diluted)
DTIL
DTIL
SWAG
SWAG
Q4 25
$2.62
$0.02
Q3 25
$-1.84
$-0.07
Q2 25
$-2.13
$0.03
Q1 25
$-2.21
$-0.02
Q4 24
$-0.02
Q3 24
$-2.25
$-0.11
Q2 24
$4.67
$-0.06
Q1 24
$1.70
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DTIL
DTIL
SWAG
SWAG
Cash + ST InvestmentsLiquidity on hand
$115.6M
$11.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$92.2M
$30.5M
Total Assets
$154.4M
$49.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DTIL
DTIL
SWAG
SWAG
Q4 25
$115.6M
$11.6M
Q3 25
$44.9M
$11.8M
Q2 25
$62.2M
$18.1M
Q1 25
$77.2M
$12.2M
Q4 24
$86.3M
$18.2M
Q3 24
$101.2M
$6.9M
Q2 24
$123.6M
$9.6M
Q1 24
$137.8M
$10.7M
Stockholders' Equity
DTIL
DTIL
SWAG
SWAG
Q4 25
$92.2M
$30.5M
Q3 25
$16.6M
$30.2M
Q2 25
$34.1M
$31.8M
Q1 25
$49.3M
$31.3M
Q4 24
$56.4M
$31.6M
Q3 24
$64.9M
$32.3M
Q2 24
$74.7M
$34.3M
Q1 24
$37.2M
$35.2M
Total Assets
DTIL
DTIL
SWAG
SWAG
Q4 25
$154.4M
$49.3M
Q3 25
$93.5M
$50.3M
Q2 25
$108.9M
$61.2M
Q1 25
$124.4M
$52.2M
Q4 24
$136.4M
$55.1M
Q3 24
$153.3M
$48.8M
Q2 24
$165.8M
$46.6M
Q1 24
$184.7M
$47.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DTIL
DTIL
SWAG
SWAG
Operating Cash FlowLast quarter
$-11.3M
$161.0K
Free Cash FlowOCF − Capex
$-11.3M
$38.0K
FCF MarginFCF / Revenue
-32.9%
0.1%
Capex IntensityCapex / Revenue
0.1%
0.4%
Cash ConversionOCF / Net Profit
-0.56×
0.66×
TTM Free Cash FlowTrailing 4 quarters
$-5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DTIL
DTIL
SWAG
SWAG
Q4 25
$-11.3M
$161.0K
Q3 25
$-15.3M
$-5.4M
Q2 25
$-20.3M
$6.4M
Q1 25
$-19.1M
$-5.9M
Q4 24
$-58.4M
$1.3M
Q3 24
$-5.9M
$-2.7M
Q2 24
$-14.9M
$2.1M
Q1 24
$-19.0M
$2.1M
Free Cash Flow
DTIL
DTIL
SWAG
SWAG
Q4 25
$-11.3M
$38.0K
Q3 25
$-5.9M
Q2 25
$-20.3M
$6.3M
Q1 25
$-19.1M
$-6.0M
Q4 24
$-58.7M
$1.2M
Q3 24
$-6.0M
$-2.9M
Q2 24
$-14.9M
$1.9M
Q1 24
$-19.1M
$1.9M
FCF Margin
DTIL
DTIL
SWAG
SWAG
Q4 25
-32.9%
0.1%
Q3 25
-22.6%
Q2 25
-112627.8%
19.5%
Q1 25
-65917.2%
-21.0%
Q4 24
-9199.8%
4.6%
Q3 24
-1033.2%
-14.3%
Q2 24
-29.9%
11.6%
Q1 24
-108.4%
9.9%
Capex Intensity
DTIL
DTIL
SWAG
SWAG
Q4 25
0.1%
0.4%
Q3 25
0.0%
1.9%
Q2 25
11.1%
0.2%
Q1 25
220.7%
0.4%
Q4 24
39.2%
0.3%
Q3 24
6.8%
0.7%
Q2 24
0.1%
1.1%
Q1 24
0.5%
1.0%
Cash Conversion
DTIL
DTIL
SWAG
SWAG
Q4 25
-0.56×
0.66×
Q3 25
Q2 25
9.99×
Q1 25
Q4 24
Q3 24
Q2 24
-0.45×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DTIL
DTIL

Segment breakdown not available.

SWAG
SWAG

Promotional Products Dropshipping$11.2M39%
Casino Continuity Program$6.9M24%
Promotional Products Company Owned Inventory$4.6M16%
Promotional Products Bulk Dropshipping$3.8M13%
Promotional Products Thirdparty Distributor$1.8M6%
Other$610.0K2%

Related Comparisons